CIM
HRTX icon

CIM Investment Management’s Heron Therapeutics HRTX Stock Holding History

CIM Investment Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,160
Closed -$243K – 260
2019
Q3 		$243K Hold
13,160
– – 0.09% 280
2019
Q2 		$245K Sell
13,160
-280
-2% -$5.59K 0.09% 275
2019
Q1 		$328K Buy
+13,440
New +$352K 0.13% 222

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CIM Investment Management's HRTX Position: Q4 2019 in Review

CIM Investment Management sold out of Heron Therapeutics (HRTX) in Q4 2019, closing a stake of 13,160 shares — an estimated $243K sold.

CIM Investment Management first reported a position in HRTX in Q1 2019 and held it in 3 quarters. The position peaked at $328K in Q1 2019. 199 funds tracked by Wall St. Rank hold HRTX as of Q4 2019.

  • CIM Investment Management reported no remaining Heron Therapeutics position as of Q4 2019 after selling out during the quarter.
  • CIM Investment Management sold 13,160 Heron Therapeutics shares in Q4 2019, an estimated $243K.
  • CIM Investment Management first reported a position in Heron Therapeutics in Q1 2019 and held it in 3 quarters.
  • CIM Investment Management's Heron Therapeutics position peaked at $328K in Q1 2019.
  • 199 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2019.

Based on CIM Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.